The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Vinnikova M.A.

Sechenov First Moscow State Medical University (Sechenov University);
Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare

Skryabin V.Yu.

Moscow Research and Practical Centre of Addictions

Clinical variants of psychoses in patients using synthetic cannabinoids (Spice)

Authors:

Vinnikova M.A., Skryabin V.Yu.

More about the authors

Read: 5300 times


To cite this article:

Vinnikova MA, Skryabin VYu. Clinical variants of psychoses in patients using synthetic cannabinoids (Spice). S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(8):23‑26. (In Russ.)
https://doi.org/10.17116/jnevro202012008123

Recommended articles:
Differential diagnosis of Alzheimer’s disease and vascular cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):26-35
Modern concepts of sleep disturbances asso­ciated with mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):7-12
Factors supporting chro­nic inflammation in mental illness. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):7-15
MR imaging of cyto­toxic lesion of the corpus callosum during pneumonia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):140-144
OCT patterns as a source of errors in the diagnosis of intraocular tumors. Russian Annals of Ophthalmology. 2025;(3):63-70
Machine learning models for brain tumors differential diagnosis. Russian Journal of Preventive Medi­cine. 2025;(9):87-93
Acne conglobata and acne fulminans. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(5):666-674

References:

  1. World Drug Report. 2015. Date: 10.07.18.  https://www.unodc.org/documents/wdr2015/WDR15_ExSum_R.pdf
  2. World Drug Report. 2013. Date: 10.07.18.  https://www.unodc.org/unodc/secured/wdr/wdr2013/WDR2013ExSum_R.pdf
  3. Patrikeeva ON, Ovchinnikov AA, Kormilina OM. Intoxication psychoses consumers of synthetic cannabinoids. Narcology. 2015;1(157):41-44. (In Russ.)
  4. Sofronov GA, Golovko AI, Barinov VA, Basharin VA, Bonitenko EYu, Ivanov MV. Synthetic cannabinoids. State of the problem. Narcology. 2012; 10:97-110. (In Russ.)
  5. Mechoulam R, Feigenbaum JJ, Lander N, Segal M, Järbe TU, Hiltunen AJ, Consroe P. Enantiomeric cannabinoids: stereospecificity of psychotropic activity. Experientia. 1988;9(44):762-764. 
  6. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;9584(370):319-328. 
  7. Müller H, Sperling W, Köhrmann M, Huttner HB, Kornhuber J, Maler JM. The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophrenia Research. 2010; 1-3(118):309-310. 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.